Execution risk is ungoverned. NAVETRA gives leadership a way to measure and govern it.

Know whether the organization can deliver — before the capital is committed.

Every major investment assumes the organization has the alignment, capacity, and operating conditions required to execute it. Financial models price market, credit, technology, and project risk — they rarely quantify the risk inside the organization expected to deliver the decision.

NAVETRA establishes an evidence-based range of operating profit exposed to execution conditions, identifies where that exposure is concentrated, and gives leadership a repeatable way to govern it.

For major transformations, growth programs, acquisitions, ERP and AI investments, restructures, and operating-model changes.

When NAVETRA becomes relevant

Major capital commitment Transformation or ERP AI adoption Acquisition or integration Growth and hiring wave Restructuring New market or operating-model change
The missing measurement

Every risk on the register has an owner. Except one.

The organizational assumptions between the decision leadership approves and the result the business expects rarely have an owner, a measure, or a reporting line.

Risk
Owner
Measure
Review cycle
Financial
CFO
VaR, covenants
Quarterly
Market
CFO / Treasury
Sensitivity, hedges
Continuous
Credit
CRO
Ratings, exposure
Monthly
Cyber
CISO
Posture, incidents
Continuous
Regulatory
GC / Compliance
Findings, audits
Quarterly
Execution

Finance, ERP, project, people, and risk systems each see part of the picture. None of them carries a line called execution exposure.

What NAVETRA establishes

One enterprise measure, with the evidence underneath it

NAVETRA measures where execution exposure is concentrated, expresses it as an evidence-weighted range of operating profit exposure, and tracks how the conditions change over time.

01

Execution exposure range

An evidence-weighted range of operating profit exposed to the execution conditions in scope — a range, not false precision.

02

Evidence confidence and coverage

How strong the evidence is, where it comes from, and how much of the organization it covers — visible alongside the range.

03

Exposure by domain and unit

Where the exposure concentrates — across ten execution domains and across the business units expected to deliver.

04

Ranked conditions

The three execution conditions contributing most to the measured exposure — where attention moves first.

05

Scenario comparison

Compare major investment decisions with the organizational exposure attached to them, before commitment.

06

Change over time

Each read is held against the organization's own record — what changed, what remained stable, and which interventions were associated with movement.

The operating loop

Repeated at the cadence the decision requires

Quarterly for continuous governance — or around major investment, growth, transformation, and delivery milestones.

01

Baseline

Establish the exposure range before commitment — while the decision is still open.

02

Prioritize

The conditions contributing most to the measured exposure emerge, ranked.

03

Act

Leadership decides the interventions against the conditions in scope.

04

Re-test

Re-read after a material operating change — a hiring wave, a go-live, an integration step.

05

Reconcile

Hold the read against what occurred. The organization's own record builds.

The seats

One measurement. Different decisions.

The same read answers a different question in each seat.

The source
One read of the organization

Ten domains, an evidence-weighted exposure range, refreshed at the decision cadence.

CEO

Can the organization deliver the strategy as designed?

CFO

What operating-profit exposure sits inside the investment case?

COO

Where is execution capacity stable, constrained, or beginning to drift?

CHRO

Which capability conditions materially affect delivery — and where will investment have the greatest business relevance?

When execution exposure remains unmeasured

The exposure doesn't disappear. It disperses.

Margin is affected indirectly

Rework, delay, additional management intervention, inconsistent adoption, and slower benefit realization appear in existing reports — but not under a line called execution risk.

Capital commits against an untested assumption

The financial case assumes the organization can absorb the decision while protecting existing performance.

Strategy and operating reality diverge

Leadership approves one direction, while capacity constraints, decision delays, dependencies, and local adaptations produce a different outcome.

When execution exposure has no owner, measure, or review cycle, an operating problem can become a governance problem.
Two ways to begin

Start from the decision in front of you

Path one · A live decision

Assess the organizational case before commitment

For a transformation, acquisition, growth program, restructuring, technology investment, or major operating decision.

Assess a live decision →
Path two · No immediate decision

Establish your baseline through the 2026 Benchmark

Understand current exposure, sector position, and priority conditions before the next demand arrives.

Join the 2026 Benchmark →

Trust and limits

Measures the organization, not individual employees
Uses ranges rather than false precision
Shows evidence coverage and confidence
Can conclude that evidence is insufficient
Does not replace management judgment

What decision is your organization preparing to make that assumes it can execute?

Define the first read →
NAVETRA™ NAVETRA™ is an execution-intelligence product of Purple Wins Inc. © 2026 Purple Wins Inc. All rights reserved.

NAVETRA provides probabilistic decision-support information based on supplied data, structured observations, assumptions and reference information. OPaR is not an audited financial measure, a prediction of a specific loss, professional financial or investment advice, or a guarantee of organizational performance. Results should be reviewed with the organization's own financial, legal, risk and operational advisers. NAVETRA, its methodology, taxonomies, model architecture, software, visualizations and associated materials are owned by or licensed to Purple Wins Inc. No licence is granted except as expressly provided in writing.